Tumors are able to form with no DNA mutations, fly study shows

In memoriam: Barbara Summers, former chief nursing officer at MD Anderson

Barbara Summers, a pioneering nurse leader, mentor and champion of patient-centered care, died May 6, in Richmond, Virginia, surrounded by her family.

May 23, 2025

Vol.51 No.20

Clinical Roundup

Study uncovers source of genetic variation influencing childhood brain tumors

Researchers at Baylor College of Medicine and collaborating institutions investigated for the first time in cancer the association between two sources of genetic variation: germline or inherited structural variation, which refers to large differences in the DNA sequence, and DNA methylation, which is when genes are turned on or off without altering the DNA code.

May 23, 2025

Vol.51 No.20

Clinical Roundup

Genetic mutation in some Ashkenazi Jewish men may be linked to higher prostate cancer risk, study shows

A Johns Hopkins Medicine-led research team has identified a recurrent frameshift mutation, called F722fs, in the MMS22L gene among men of Ashkenazi Jewish ancestry that is associated with a higher risk of prostate cancer and increased sensitivity to a specific anticancer therapy.

May 23, 2025

Vol.51 No.20

Clinical Roundup

Wistar scientists uncover new viral mechanism for evading immunity, identifying a new drug target

Researchers at The Wistar Institute have identified a previously unknown mechanism by which viruses can reprogram mitochondrial structure to silence immune responses and ensure successful viral reproduction.

May 23, 2025

Vol.51 No.20

In Brief

Texas Children’s and MD Anderson receive $150M gift from Kinder Foundation to launch Kinder Children’s Cancer Center

Texas Children’s Hospital and The University of Texas MD Anderson Cancer Center announced a $150 million gift from Kinder Foundation.

May 16, 2025

Vol.51 No.19

In Brief

Swim Across America grants $900,000 toward gene editing innovation

Joseph FraiettaPietro GenoveseSwim Across America, the nonprofit funding innovative clinical trials and patient-centered programs for cancer, awarded $450,000 grants to two of its beneficiaries, Alliance for Cancer Gene Therapy and Dana-Farber Cancer Institute, to support the work of novel gene and base editing techniques used in advanced cancer research, including targeted therapies, immunotherapies, and cellular therapies.

April 25, 2025

Vol.51 No.16

Tumors are able to form with no DNA mutations, fly study shows

YOU MAY BE INTERESTED IN

In memoriam: Barbara Summers, former chief nursing officer at MD Anderson

Study uncovers source of genetic variation influencing childhood brain tumors

Genetic mutation in some Ashkenazi Jewish men may be linked to higher prostate cancer risk, study shows

Wistar scientists uncover new viral mechanism for evading immunity, identifying a new drug target

Texas Children’s and MD Anderson receive $150M gift from Kinder Foundation to launch Kinder Children’s Cancer Center

Swim Across America grants $900,000 toward gene editing innovation

Renew today!

Subscriber content

Never miss an issue!

Login